HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Kevin H. Teoh George T. Christakis Richard D. Weisel Arnold Benak Michael F.X. Glynn Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Teoh, K. H. Articles by Glynn, M. F. X. Search for Related Content PubMed PubMed Citation Articles by Teoh, K. H. Articles by Glynn, M. F. X.

Ann Thorac Surg 1987;44:40-47
© 1987 The Society of Thoracic Surgeons

---

Articles

Blood Conservation with Membrane Oxygenators and Dipyridamole

From the Divisions of Cardiovascular Surgery, Clinical Biochemistry, Hematology, and Pharmacology, Toronto General Hospital and the University of Toronto, Toronto, Ont, Canada

Accepted for publication November 26, 1986.

Cardiopulmonary bypass induces platelet activation and dysfunction, which result in platelet deposition and depletion. Reduced platelet numbers and abnormal platelet function may contribute to postoperative bleeding. A membrane oxygenator may preserve platelets and reduce bleeding more than a bubble oxygenator, and the antiplatelet agent dipyridamole may protect platelets intraoperatively and reduce bleeding postoperatively. A prospective randomized trial was performed in 44 patients undergoing elective coronary artery bypass grafting to assess the effects of the membrane oxygenator and dipyridamole on platelet counts, platelet activation products, and postoperative bleeding. Patients who were randomized to receive a bubble oxygenator and no dipyridamole had the lowest postoperative platelet counts, the greatest blood loss, and the most blood products transfused. Platelet counts were highest and blood loss was least in patients randomized to receive a membrane oxygenator and dipyridamole (p < .05). A bubble oxygenator with dipyridamole and a membrane oxygenator without dipyridamole resulted in intermediate postoperative platelet counts and blood loss. Arterial thromboxane B₂ and platelet factor 4 concentrations were elevated on cardiopulmonary bypass in all groups. Both the membrane oxygenator and dipyridamole were independently effective (by multivariate analysis) in preserving platelets. Optimal blood conservation was achieved with a membrane oxygenator and dipyridamole.

This article has been cited by other articles:

				M. Makar, J. Taylor, M. Zhao, A. Farrohi, M. Trimming, and N. D'Attellis Perioperative Coagulopathy, Bleeding, and Hemostasis During Cardiac Surgery: A Comprehensive Review ICU Director, January 1, 2010; 1(1): 17 - 27. [Abstract] [PDF]

				G. J. Despotis, M. S. Avidan, and C. W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann. Thorac. Surg., November 1, 2001; 72(5): S1821 - S1831. [Abstract] [Full Text] [PDF]

				A. Weerasinghe and K. M. Taylor The platelet in cardiopulmonary bypass Ann. Thorac. Surg., December 1, 1998; 66(6): 2145 - 2152. [Abstract] [Full Text] [PDF]

				R. G. H. Speekenbrink, A. B. A. Vonk, C. R. H. Wildevuur, and L. Eijsman Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting Ann. Thorac. Surg., February 1, 1995; 59(2): 438 - 442. [Abstract] [PDF]

				Antiplatelet Trialists Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ, January 8, 1994; 308(6921): 81 - 106. [Abstract] [Full Text]

				Z. A Varga Autologous plateletpheresis in cardiac surgery Perfusion, November 1, 1993; 8(6): 471 - 476. [Abstract] [PDF]

				M. Kawasuji, K. Ueyama, N. Sakakibara, T. Tedoriya, Y. Matsunaga, T. Misaki, and Y. Watanabe Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass Ann. Thorac. Surg., May 1, 1993; 55(5): 1205 - 1209. [Abstract] [PDF]

				R. D Weisel Agents that modify haemostasis after cardiopulmonary bypass Perfusion, May 1, 1993; 8(1_suppl): 6 - 12. [Abstract] [PDF]

				D. M Cosgrove Use of aprotinin in repeat myocardial revascularization: Cleveland Clinic experience Perfusion, May 1, 1993; 8(1_suppl): 36 - 42. [Abstract] [PDF]

				D. Tixier, D. Loisance, P. Deleuze, M. Hillion, H. Jouault, G. Bajan, and J. Cachera Blood saving in cardiac surgery: simple approach and tendencies Perfusion, October 1, 1991; 6(4): 265 - 273. [PDF]

				J. Driessen, G. Fransen, L. Rondelez, E. Schelstraete, and L. Gevaert Comparison of the standard roller pump and a pulsatile centrifugal pump for extracorporeal circulation during routine coronary artery bypass grafting Perfusion, October 1, 1991; 6(4): 303 - 311. [Abstract] [PDF]

				M. Sellman, T. Ivert, M. Blomback, and B. Semb Haematological effects of a depth absorption arterial line filter during extracorporeal circulation Perfusion, October 1, 1989; 4(4): 255 - 264. [Abstract] [PDF]

				B. P Bidstrup Review article : Blood conservation in cardiac surgery: can drugs help? Perfusion, July 1, 1988; 3(3): 171 - 177. [PDF]

				G. A. Patterson, J. D. Cooper, B. Goldman, R. D. Weisel, F. G. Pearson, P. F. Waters, T. R. Todd, H. Scully, M. Goldberg, and R. J. Ginsberg Technique of Successful Clinical Double-Lung Transplantation Ann. Thorac. Surg., June 1, 1988; 45(6): 626 - 633. [Abstract] [PDF]